Skip to Main Content
Table 2—

Baseline characteristics of subjects with no retinopathy at baseline

Intervention groupControl groupSignificance
Number (male/female) 61 (15/46) 49 (15/34) P = 0.841 
Age (years) 53.5 (12.4) 53.5 (13.9) P = 0.997 
Ethnicity    
    Non-Hispanic white 22 20 P = 0.930 
    Hispanic 26 19  
    Black  
    Other  
A1C (%) 9.6 ± 1.6 9.7 ± 1.8 P = 0.638 
Diabetes duration (years) 7.3 ± 5.4 7.5 ± 8.3 P = 0.921 
Follow-up time (months) 19.9 ± 8.4 24.0 ± 8.9 P = 0.019* 
Dropouts (total) 13 15 P = 0.372 
    Withdraw/move P = 0.384 
    Loss of benefit  
    Death  
    Loss to follow-up  
    No second photo  
Intervention groupControl groupSignificance
Number (male/female) 61 (15/46) 49 (15/34) P = 0.841 
Age (years) 53.5 (12.4) 53.5 (13.9) P = 0.997 
Ethnicity    
    Non-Hispanic white 22 20 P = 0.930 
    Hispanic 26 19  
    Black  
    Other  
A1C (%) 9.6 ± 1.6 9.7 ± 1.8 P = 0.638 
Diabetes duration (years) 7.3 ± 5.4 7.5 ± 8.3 P = 0.921 
Follow-up time (months) 19.9 ± 8.4 24.0 ± 8.9 P = 0.019* 
Dropouts (total) 13 15 P = 0.372 
    Withdraw/move P = 0.384 
    Loss of benefit  
    Death  
    Loss to follow-up  
    No second photo  

Data are means ± SD, unless otherwise indicated.

Close Modal

or Create an Account

Close Modal
Close Modal